À´×Ôɽ¶«£ºPD-1/VEGFË«¿¹ £¬Äâ±»ÄÉÈëÍ»ÆÆÐÔÁÆ·¨ ×îлØÓ¦£¡Æ½°²ÈËÊÙÓëÆ½°²¿µ½¡ÏÕµÄӪҵЭ×÷ϵ¡°Õý³£µ÷½â¡± Ê®Äêδ»Ø±¾¡°ÏûºÄ»ù¡±£ºÌìÖÎÐÂÏûºÄ½üÊ®Äêµø55%¾ÓÊ× £¬»ù½ð˾ÀíÁºÀòÈÎÆÚ»Ø±¨¸º56.71% ¸Û»ªÖÇ»ÛÄÜÔ´Ðû²¼ÖÐÆÚÒµ¼¨ ÓªÒµ½¹µãÀûÈó7.19ÒÚ¸ÛԪͬ±ÈÔöÌí1.7% ÑëÐÐÍÑÊÖ£¡Ò»Á¬9¸öÔ¹º½ð£¡»ú¹¹ÕâÑù¿´ ¡°00ºó¡±Åܲ½½ø¹ÉÊÐ £¬Ó¶½ðɱµ½¡°Íò1¡±£¡ÐÂÒ»ÂÖ¿ª»§³±À´ÁË ÃÉÌ©·¶¼Ò´åú¿óÍøÂ羺¼Ûͨ¸æ ÃÀÁª´¢½µÏ¢Ô¤ÆÚ½µÎÂÍÆ¶¯ÃÀÔª¼áͦ £¬»Æ½ðÒ»Á¬Á½ÈÕ³ÐѹáÝáåÔÚ3330ÃÀÔªÖÜΧ A¹É3600µãáÝá壺¹ÉÊС°ÀÏ˾»ú¡±Âä´üΪ°² £¬ÓÐÈËÈ´ÒªÄóöÂò·¿Ê׸¶ÈëÊРȯÉÌ´į̂¡¢A¹É³ªÏ· £¬ÐÐÇéÆìÍ·½«ÒýÁìÊг¡×ßÏòºÎ·½£¿